Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage, for any covered stock.
TapClick below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
TapClick below to see what's inside, then upgrade to unlock for CLMT and 80,000+ other tickers.
See price against where its own fundamentals say it should trade. The shaded gap is the discount or premium, across five valuation lenses.
TapClick below to see what's inside, then upgrade to unlock for CLMT and 80,000+ other tickers.
See exactly how CLMT's revenue becomes profit: a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CLMT and 80,000+ other tickers.
Calumet, Inc. engages in the manufacturing, formulation, and sale of specialty branded products and renewable fuel. It operates through the following segments: Specialty Products and Solutions, Montana/Renewables, Performance Brands, and Corporate. The Specialty Products & Solutions segment consists of customer-focused solutions and formulation businesses. The Montana/Renewables segment is composed of a Great Falls specialty asphalt facility and Montana Renewables facility. The Performance Brands segment includes Royal Purple, Bel-Ray, and TruFuel. The Corporate segment focuses on the general…
Here is how Calumet, Inc. (CLMT) and ConocoPhillips (COP) have performed compared to their sector so far this year.
INDIANAPOLIS, Oct. 15, 2026 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company" or "Calumet") today announced that its wholly owned subsidiaries, Calumet Specialty Products Partners, L.P. (the "Partnership") and Calumet Finance Corp. (together with the Partnership, the "Issuers"), have given notice for redemption of $150 million of the outstanding 9.75% Senior Notes due 2028 (CUSIP Nos.
Calumet Specialty Products (CLMT) is poised to deliver a potentially stunning Q3 EBITDA of $300–$325 million, driven by strong crack spreads and operational improvements. Current valuation appears rich, with technical indicators overbought and EBITDA run rates well above normalized levels, suggesting a correction may be imminent. I am lowering my rating from strong buy to buy, recommending investors wait until after earnings and the planned Shreveport shutdown before adding shares.
REPYY, TGT and CLMT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 13, 2026.
ROKU, FET, CLMT, FTI and SHEL stand out after a screen identified stocks with efficiency ratios above their industry averages.